Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 5,1x - 5,7x | 5,4x |
| Selected Fwd Revenue Multiple | 5,0x - 5,6x | 5,3x |
| Fair Value | 808,29₹ - 907,10₹ | 857,69₹ |
| Upside | -45,3% - -38,6% | -42,0% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Medico Remedies Limited | MEDICO | NSEI:MEDICO |
| Zydus Lifesciences Limited | ZYDUSLIFE | NSEI:ZYDUSLIFE |
| Lupin Limited | LUPIN | NSEI:LUPIN |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO | NSEI:GLAXO |
| Alembic Pharmaceuticals Limited | APLLTD | NSEI:APLLTD |
| Wockhardt Limited | WOCKPHARMA | NSEI:WOCKPHARMA |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| MEDICO | ZYDUSLIFE | LUPIN | GLAXO | APLLTD | WOCKPHARMA | |||
| NSEI:MEDICO | NSEI:ZYDUSLIFE | NSEI:LUPIN | NSEI:GLAXO | NSEI:APLLTD | NSEI:WOCKPHARMA | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 8.2% | 8.2% | 6.4% | 2.0% | 9.6% | -4.5% | ||
| 3Y CAGR | 5.8% | 10.7% | 9.7% | 5.7% | 4.9% | 1.5% | ||
| Latest Twelve Months | 14.7% | 16.9% | 12.9% | 11.9% | 4.9% | 8.1% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 4.4% | 18.9% | 10.1% | 22.0% | 14.7% | -3.3% | ||
| Prior Fiscal Year | 4.9% | 16.6% | 5.1% | 23.0% | 7.7% | -5.4% | ||
| Latest Fiscal Year | 6.9% | 23.2% | 13.9% | 24.3% | 10.6% | -0.7% | ||
| Latest Twelve Months | 6.6% | 24.6% | 18.8% | 27.8% | 11.2% | 5.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 2.86x | 4.16x | 4.42x | 12.89x | 3.06x | 9.04x | ||
| EV / LTM EBIT | 43.3x | 16.9x | 23.5x | 46.3x | 27.4x | 173.8x | ||
| Price / LTM Sales | 2.80x | 4.15x | 4.39x | 13.46x | 2.92x | 8.22x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 2.86x | 4.16x | 12.89x | |||||
| Historical EV / LTM Revenue | 1.30x | 2.07x | 4.12x | |||||
| Selected EV / LTM Revenue | 5.14x | 5.41x | 5.68x | |||||
| (x) LTM Revenue | 30,010 | 30,010 | 30,010 | |||||
| (=) Implied Enterprise Value | 154,218 | 162,335 | 170,452 | |||||
| (-) Non-shareholder Claims * | (21,200) | (21,200) | (21,200) | |||||
| (=) Equity Value | 133,018 | 141,135 | 149,252 | |||||
| (/) Shares Outstanding | 162.5 | 162.5 | 162.5 | |||||
| Implied Value Range | 818.65 | 868.60 | 918.55 | |||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 818.65 | 868.60 | 918.55 | 1,477.95 | ||||
| Upside / (Downside) | -44.6% | -41.2% | -37.8% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | MEDICO | ZYDUSLIFE | LUPIN | GLAXO | APLLTD | WOCKPHARMA | |
| Enterprise Value | 3,944 | 906,413 | 973,146 | 467,429 | 197,908 | 261,346 | |
| (+) Cash & Short Term Investments | 15 | 24,950 | 29,123 | 21,108 | 1,290 | 2,230 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (114) | (1,905) | (34,425) | (148) | (10,664) | (23,430) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 3,845 | 929,458 | 967,844 | 488,389 | 188,534 | 240,146 | |
| (/) Shares Outstanding | 83.0 | 1,006.2 | 456.5 | 169.4 | 196.6 | 162.5 | |
| Implied Stock Price | 46.34 | 923.70 | 2,119.95 | 2,882.95 | 959.15 | 1,477.95 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 46.34 | 923.70 | 2,119.95 | 2,882.95 | 959.15 | 1,477.95 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |